LMN diet, rich in polyphenols and polyunsaturated fatty acids, improves mouse cognitive decline associated with aging and Alzheimer's disease

Behavioural Brain Research

Volumn 228, Issue 2, 2012, Pages 261-271

  Fernández Fernández, Laura ^a   Comes, Gemma ^b   Bolea, Irene ^a   Valente, Tony ^a   Ruiz, Jessica ^b   Murtra, Patricia ^a   Ramirez, Bartolomé ^c   Anglés, Neus ^c   Reguant, Jordi ^c   Morelló, José Ramón ^c   Boada, Mercè ^d   Hidalgo, Juan ^b   Escorihuela, Rosa María ^b   Unzeta, Mercedes ^a  

^a INSTITUT DE NEUROCIÈNCIES   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c La Morella Nuts SA   (Spain)

^d Fundacion ACE   (Spain)

Author keywords

Aging; Alzheimer's disease; Memory and learning; Polyphenols; Polyunsaturated fatty acids

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; POLYPHENOL; POLYUNSATURATED FATTY ACID;

AGING; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CACAO; CELL PROLIFERATION; COGNITIVE DEFECT; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FRUIT; GENOTYPE; LMN DIET; MALE; MAZE TEST; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; SUBVENTRICULAR ZONE; TASK PERFORMANCE;

AGE FACTORS; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; BROMODEOXYURIDINE; CELL PROLIFERATION; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FATTY ACIDS, UNSATURATED; HUMANS; LEARNING; MALE; MAZE LEARNING; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MUSCLE STRENGTH; MUTATION; PLAQUE, AMYLOID; POLYPHENOLS; POSTURAL BALANCE; REACTION TIME; REFLEX; SENSORY GATING;

EID: 84856215978     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.11.014     Document Type: Article

References (70)

1. Dodge H.H., Wang C.N., Chang C.C., Ganguli M. Terminal decline and practice effects in older adults without dementia: the MoVIES project. Neurology 2011, 77:722-730.
2. Villeda S.A., Luo J., Mosher K.I., Zou B., Britschgi M., Bieri G., et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 2011, 477:90-94.
3. Esposito E., Rotilio D., Di Matteo V., Di Giulio C., Cacchio M., Algeri S. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol Aging 2002, 23:719-735.
4. Guo W., Kong E., Meydani M. Dietary polyphenols, inflammation, and cancer. Nutr Cancer 2009, 61:807-810.
5. Covas M.I., Gambert P., Fito M., de la T.R. Wine and oxidative stress: up-to-date evidence of the effects of moderate wine consumption on oxidative damage in humans. Atherosclerosis 2010, 208:297-304.
6. Xu J., Guo C.J., Yang J.J., Wei J.Y., Li Y.F., Pang W., et al. Intervention of antioxidant system function of aged rats by giving fruit juices with different antioxidant capacities. Zhonghua Yu Fang Yi Xue Za Zhi 2005, 39:80-83.
7. Hooijmans C.R., Kiliaan A.J. Fatty acids, lipid metabolism and Alzheimer pathology. Eur J Pharmacol 2008, 585:176-196.
8. Luchsinger J.A., Tang M.X., Shea S., Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch Neurol 2002, 59:1258-1263.
9. Harwood D.G., Kalechstein A., Barker W.W., Strauman S., St George-Hyslop P., Iglesias C., et al. The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer's disease. Int J Geriatr Psychiatry 2010, 25:511-518.
10. Ramesh B.N., Rao T.S., Prakasam A., Sambamurti K., Rao K.S. Neuronutrition and Alzheimer's disease. J Alzheimer's Dis 2010, 19:1123-1139.
11. Joseph J.A., Shukitt-Hale B., Casadesus G., Fisher D. Oxidative stress and inflammation in brain aging: nutritional considerations. Neurochem Res 2005, 30:927-935.
12. Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 2006, 545:51-64.
13. Asha D.S., Sagar Chandrasekar B.K., Manjula K.R., Ishii N. Grape seed proanthocyanidin lowers brain oxidative stress in adult and middle-aged rats. Exp Gerontol 2011, 46:958-964.
14. Valente T., Hidalgo J., Bolea I., Ramirez B., Anglés N., Reguant J., et al. A diet enriched in polyphenols and polyunsaturated fatty acids, LMN diet, induces neurogenesis in the subventricular zone and hippocampus of adult mouse brain. J Alzheimer's Dis 2009, 18:849-865.
15. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996, 274:99-102.
16. Lamberty Y., Gower A.J. Age-related changes in spontaneous behavior and learning in NMRI mice from middle to old age. Physiol Behav 1992, 51:81-88.
17. File S.E., Wardill A.G. Validity of head-dipping as a measure of exploration in a modified hole-board. Psychopharmacologia 1975, 44:53-59.
18. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 1987, 92:180-185.
19. Llagostera E., Carmona M.C., Vicente M., Escorihuela R.M., Kaliman P. High-fat diet induced adiposity and insulin resistance in mice lacking the myotonic dystrophy protein kinase. FEBS Lett 2009, 583:2121-2125.
20. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984, 11:47-60.
21. Parachikova A., Green K.N., Hendrix C., LaFerla F.M. Formulation of a medical food cocktail for Alzheimer's disease: beneficial effects on cognition and neuropathology in a mouse model of the disease. PLoS One 2010, 5:e14015.
22. Carlson G.A., Borchelt D.R., Dake A., Turner S., Danielson V., Coffin J.D., et al. Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Hum Mol Genet 1997, 6:1951-1959.
23. Deacon R.M., Cholerton L.L., Talbot K., Nair-Roberts R.G., Sanderson D.J., Romberg C., et al. Age-dependent and -independent behavioral deficits in Tg2576 mice. Behav Brain Res 2008, 189:126-138.
24. Kohjima M., Sun Y., Chan L. Increased food intake leads to obesity and insulin resistance in the tg2576 Alzheimer's disease mouse model. Endocrinology 2010, 151:1532-1540.
25. Hayes N.L., Nowakowski R.S. Dynamics of cell proliferation in the adult dentate gyrus of two inbred strains of mice. Brain Res Dev Brain Res 2002, 134:77-85.
26. Zanto T.P., Pan P., Liu H., Bollinger J., Nobre A.C., Gazzaley A. Age-related changes in orienting attention in time. J Neurosci 2011, 31:12461-12470.
27. Cimini A., Moreno S., D'Amelio M., Cristiano L., D'Angelo B., Falone S., et al. Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer's disease: a role for peroxisomes. J Alzheimer's Dis 2009, 18:935-952.
28. Sesti F., Liu S., Cai S.Q. Oxidation of potassium channels by ROS: a general mechanism of aging and neurodegeneration?. Trends Cell Biol 2010, 20:45-51.
29. Cai S.Q., Sesti F. Oxidation of a potassium channel causes progressive sensory function loss during aging. Nat Neurosci 2009, 12:611-617.
30. Joseph J., Cole G., Head E., Ingram D. Nutrition, brain aging, and neurodegeneration. J Neurosci 2009, 29:12795-12801.
31. Joseph J.A., Shukitt-Hale B., Casadesus G. Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. Am J Clin Nutr 2005, 81:313S-316S.
32. Inoue H., Jiang X.F., Katayama T., Osada S., Umesono K., Namura S. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice. Neurosci Lett 2003, 352:203-206.
33. Joyal C.C., Beaudin S., Lalonde R. Longitudinal age-related changes in motor activities and spatial orientation in CD-1 mice. Arch Physiol Biochem 2000, 108:248-256.
34. Brown M.K., Naidoo N. The UPR and the anti-oxidant response: relevance to sleep and sleep loss. Mol Neurobiol 2010, 42:103-113.
35. King D.L., Arendash G.W. Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol Behav 2002, 75:627-642.
36. Ognibene E., Middei S., Daniele S., Adriani W., Ghirardi O., Caprioli A., et al. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease. Behav Brain Res 2005, 156:225-232.
37. Gil-Bea F.J., Aisa B., Schliebs R., Ramirez M.J. Increase of locomotor activity underlying the behavioral disinhibition in tg2576 mice. Behav Neurosci 2007, 121:340-344.
38. Lalonde R., Lewis T.L., Strazielle C., Kim H., Fukuchi K. Transgenic mice expressing the betaAPP695SWE mutation: effects on exploratory activity, anxiety, and motor coordination. Brain Res 2003, 977:38-45.
39. Harms M.P., Kotyk J.J., Merchant K.M. Evaluation of white matter integrity in ex vivo brains of amyloid plaque-bearing APPsw transgenic mice using magnetic resonance diffusion tensor imaging. Exp Neurol 2006, 199:408-415.
40. Arendash G.W., King D.L. Intra- and intertask relationships in a behavioral test battery given to Tg2576 transgenic mice and controls. Physiol Behav 2002, 75:643-652.
41. Corcoran K.A., Lu Y., Turner R.S., Maren S. Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease. Learn Mem 2002, 9:243-252.
42. Horgan J., Miguel-Hidalgo J.J., Thrasher M., Bissette G. Longitudinal brain corticotropin releasing factor and somatostatin in a transgenic mouse (TG2576) model of Alzheimer's disease. J Alzheimer's Dis 2007, 12:115-127.
43. Paul C., Ribeiro O., Santos P. Cognitive impairment in old people living in the community. Arch Gerontol Geriatr 2010, 51:121-124.
44. Sharma S., Rakoczy S., Brown-Borg H. Assessment of spatial memory in mice. Life Sci 2010, 87:521-536.
45. Joseph J.A., Denisova N.A., Arendash G., Gordon M., Diamond D., Shukitt-Hale B., et al. Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 2003, 6:153-162.
46. Hartman R.E., Shah A., Fagan A.M., Schwetye K.E., Parsadanian M., Schulman R.N., et al. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis 2006, 24:506-515.
47. Stackman R.W., Eckenstein F., Frei B., Kulhanek D., Nowlin J., Quinn J.F. Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Exp Neurol 2003, 184:510-520.
48. van Praag H. Exercise and the brain: something to chew on. Trends Neurosci 2009, 32:283-290.
49. Jin K., Minami M., Xie L., Sun Y., Mao X.O., Wang Y., et al. Ischemia-induced neurogenesis is preserved but reduced in the aged rodent brain. Aging Cell 2004, 3:373-377.
50. Klein S.M., Behrstock S., McHugh J., Hoffmann K., Wallace K., Suzuki M., et al. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 2005, 16:509-521.
51. Jin K., Peel A.L., Mao X.O., Xie L., Cottrell B.A., Henshall D.C., et al. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci USA 2004, 101:343-347.
52. Crespel A., Rigau V., Coubes P., Rousset M.C., de Bock F., Okano H., et al. Increased number of neural progenitors in human temporal lobe epilepsy. Neurobiol Dis 2005, 19:436-450.
53. Gan L., Qiao S., Lan X., Chi L., Luo C., Lien L., et al. Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer's disease-like transgenic (pPDGF-APPSw,Ind) mice. Neurobiol Dis 2008, 29:71-80.
54. Carrasco J., Adlard P., Cotman C., Quintana A., Penkowa M., Xu F., et al. Metallothionein-I and -III expression in animal models of Alzheimer disease. Neuroscience 2006, 143:911-922.
55. Chauhan N.B., Siegel G.J. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody. J Neurosci Res 2002, 69:10-23.
56. Dong H., Csernansky C.A., Martin M.V., Bertchume A., Vallera D., Csernansky J.G. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease. Psychopharmacology (Berl) 2005, 181:145-152.
57. Roberson E.D., Scearce-Levie K., Palop J.J., Yan F., Cheng I.H., Wu T., et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 2007, 316:750-754.
58. Simon A.M., de Maturana R.L., Ricobaraza A., Escribano L., Schiapparelli L., Cuadrado-Tejedor M., et al. Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease. J Alzheimer's Dis 2009, 17:773-786.
59. Gruart A., Lopez-Ramos J.C., Munoz M.D., gado-Garcia J.M. Aged wild-type and APP, PS1, and APP+PS1 mice present similar deficits in associative learning and synaptic plasticity independent of amyloid load. Neurobiol Dis 2008, 30:439-450.
60. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 2006, 440:352-357.
61. Rosenberg R.N. The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture. Neurology 2000, 54:2045-2054.
62. Ertekin-Taner N., Younkin L.H., Yager D.M., Parfitt F., Baker M.C., Asthana S., et al. Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families. Neurology 2008, 70:596-606.
63. Cosentino S.A., Stern Y., Sokolov E., Scarmeas N., Manly J.J., Tang M.X., et al. Plasma {beta}-amyloid and cognitive decline. Arch Neurol 2010, 67:1485-1490.
64. Laske C., Sopova K., Gkotsis C., Eschweiler G.W., Straten G., Gawaz M., et al. Amyloid-beta peptides in plasma and cognitive decline after 1 year follow-up in Alzheimer's disease patients. J Alzheimer's Dis 2010, 21:1263-1269.
65. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 2001, 21:372-381.
66. Kuo Y.M., Kokjohn T.A., Beach T.G., Sue L.I., Brune D., Lopez J.C. Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains. J Biol Chem 2001, 276:12991-12998.
67. Donahue J.E., Flaherty S.L., Johanson C.E., Duncan J.A., Silverberg G.D., Miller M.C., et al. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol 2006, 112:405-415.
68. Deren K.E., Forsyth J., Abdullah O., Hsu E.W., Klinge P.M., Silverberg G.D., et al. Low levels of amyloid-beta and its transporters in neonatal rats with and without hydrocephalus. Cerebrospinal Fluid Res 2009, 6:4.
69. Yan F.L., Zheng Y., Zhao F.D. Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia. Acta Neuropathol 2008, 116:529-535.
70. Sturchler E., Galichet A., Weibel M., Leclerc E., Heizmann C.W. Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity. J Neurosci 2008, 28:5149-5158.